UPDATE 1-Eli Lilly's migraine treatment wins U.S. FDA approval [Yahoo! Finance News]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance News
UPDATE 1-Eli Lilly's migraine treatment wins U.S. FDA approval ds detail about the drug, background) Oct 11 Reuters) - The U.S. Food and Drug ministration said on Friday it had approved Eli Lilly and Co's migraine drug, Reyvow. The drug has been approved to treat acute migraine with or without aura, a sensory phenomenon or visual disturbance, in adults. Lilly acquired Reyvow, formerly called lasmiditan, in a deal https://www.reuters.com/article/us-colucid-pharms-m-a-eli-lilly-idUSKBN1521O6 worth about $960 million when it bought CoLucid Pharmaceuticals Inc in early 2017. Lasmiditan was first developed at Lilly, but later licensed out to CoLucid in 2005. Lilly said the price of Reyvow will be determined closer to the time of commercial availability. According to the Migraine Research Foundation, roughly 39 million Americans suffer from migraine headaches. The FDA advises patients not to drive or operate machinery for at least eight hours after taking Reyvow, as the drug causes dizzines
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- American College Of Physicians Officially Recommends GLP-1s Like Ozempic For Diabetes Treatment—Despite Shortage Concerns [Forbes]Forbes
- Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data [Yahoo! Finance]Yahoo! Finance
- Corticosteroids Market Size Expected to Reach USD 6.91 Bn by 2033 [Yahoo! Finance]Yahoo! Finance
- As Zepbound shortage grows, Eli Lilly says there's no immediate end in sight [MSNBC.com]MSNBC.com
- The Zacks Analyst Blog Highlights Eli Lilly, Linde, Caterpillar, Salesforce, and Wells Fargo [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 2/6/24 - Miss
LLY
Sec Filings
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- LLY's page on the SEC website